🇺🇸 Placebo to Prazosin in United States

Placebo to Prazosin (Placebo to Prazosin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Placebo to Prazosin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Placebo to Prazosin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Placebo to Prazosin in United States?

Brian J Lipworth is the originator. The local marketing authorisation holder may differ — check the official source linked above.